RUN! No, seriously….run. A part of every business person’s preparation when traveling and working in emerging and frontier markets is an exit plan. Or so it should be. How
Last week JP Morgan announced the launch of a new investment fund for Africa. And hold on here…..the new fund is going to target…..pharmaceuticals! Yes, just what
India Warns It Is Running Out of TB Drug MUMBAI—India faces a potential shortage of a critical medication for drug-resistant tuberculosis that could deepen an already acute
Executives working for the UK drug maker GlaxoSmithKline in China have confessed to “serious” corruption and tax-related offences. The allegations, which the ministry
OrbiMed’s $500 million healthcare fund will join a growing field in India in particular, as well as a few other Asian countries. Not sure how well OrbiMed will like the
The GSK (GlaxoSmithKline) head recently told investors the firm may move its drug development operations away from Europe, the US and Japan because of the increasing regulatory
A newly-revamped audit of medicine sales in the country shows that drugs are selling faster in hospitals than in chemist shops suggesting that hospitals are gaining in importance
Indian listed Strides (Bombay Stock Exchange Limited, National Stock Exchange of India) to acquire Aspen’s Brazil pharmaceutical facility.
PharmaClinix, the UK’s premiere skin care products for Asian and Arab skin has now made its debut in UAE. PharmaClinix’s product range is specially designed for Asian
China has admitted that its pharmaceutical companies were involved in shipping fake drugs labeled ‘Made In India’ to Nigeria.